Use of a Cannabinoids as a Treatment Strategy for Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 13, 2024

Primary Completion Date

August 27, 2024

Study Completion Date

March 27, 2025

Conditions

Alzheimer Disease

Interventions

OTHER

Cannabis

0,2 ml of CBD:THC (50 mg:5 mg)

OTHER

Placebo

Product vehicle, medium chain triglycerides (MCT)

Trial Locations (1)

Federal University of Latin American Integration, Foz do Iguaçu

All Listed Sponsors

lead

Federal University of Latin American Integration

OTHER

NCT06570928 - Use of a Cannabinoids as a Treatment Strategy for Alzheimer's Disease | Biotech Hunter | Biotech Hunter